Amit Parhar
From Sequencer to Tumor Board: How AI-powered Genomics Platforms Are Rewriting Cancer Diagnosis and Treatment
Cancer care is undergoing a profound shift. What once took weeks of manual interpretation ...
Audit-ready, Cloud-native NGS Pipelines: Ending the Rare Disease Diagnostic Odyssey with Reproducible Science
Did you know that an average rare disease patient spends nearly five years searching for ...
AI-powered Germline Variant Interpretation: Transforming Rare Disease Diagnosis in the Era of Precision Medicine
For rare-disease patients, the diagnostic journey often stretches beyond six years and ...
How NGS and Machine Learning Are Driving 90%+ Diagnostic Performance in Lung Cancer
Global and national epidemiology shows lung cancer remains the leading cause of cancer ...
From Silos to Seamless: How API-first Ecosystems Are Redefining Genomics & Healthcare IT
The success metrics for genomics and healthcare IT projects have undergone significant ...
Reimagining Rare Disease Diagnosis with GenAI: ClairLabs’ Vision for the Future of Precision Medicine
Rare diseases account for nearly 5% of the global disease burden. With the advent of ...
